Third Quarter Consolidated Revenues of $2.68 billion, up 7% on a Reported basis and 5% on an Organic (non-GAAP)1 basis over ...

Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced its third-quarter 2025 financial results.

Q2 2026 Earnings Call Transcript October 28, 2025 Nomura Holdings, Inc. beats earnings expectations. Reported EPS is $0.206, ...

Q3 2025 Earnings Call October 29, 2025 5:00 AM EDTCompany ParticipantsIngela Ulfves - Vice President of Investor Relations ...

Amount includes $1.3 million and $(3.4) million of unrealized foreign exchange gain (loss) for the three months ended September 30, 2025 and June 30, 2025, respectively, and $(2.4) million and $1.5 ...

Third Quarter Consolidated Revenues of $2.68 billion, up 7% on a Reported basis and 5% on an Organic (non-GAAP)1 basis over the prior year periodGAAP Net Income Attributable to Bausch Health of $179 m ...